2023
DOI: 10.1016/j.thromres.2023.01.004
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of contemporary mortality trends in pulmonary embolism, United States, 1999–2020

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 28 publications
0
1
0
Order By: Relevance
“…The development of these clinical decision rule, which have reportedly reduced the use of chest imaging in their validation trials, did not succeed in such reduction in routine practice, outside of clinical research. Several studies have reported an increase in the use of computed tomographic pulmonary angiography (CTPA), yet no decrease in mortality rates, which have stayed the same over the time [7]. Studies have highlighted the substantial healthcare costs associated with CTPA utilization, particularly given the high prevalence of incidental findings and subsequent downstream testing [8].…”
mentioning
confidence: 99%
“…The development of these clinical decision rule, which have reportedly reduced the use of chest imaging in their validation trials, did not succeed in such reduction in routine practice, outside of clinical research. Several studies have reported an increase in the use of computed tomographic pulmonary angiography (CTPA), yet no decrease in mortality rates, which have stayed the same over the time [7]. Studies have highlighted the substantial healthcare costs associated with CTPA utilization, particularly given the high prevalence of incidental findings and subsequent downstream testing [8].…”
mentioning
confidence: 99%